Biotech Values

[linhdtu]

<To clarify, MNTA never had a chance to defend it's patents. The CAFC ruling had to do with safe harbour and nothing to do with the actual patents. >
Of course, I know that. I was in mnta big time and only escaped with a meager profit (relative to the amount of risk capital I had to deploy which at one time was close to a mil) due to lady fortuna's favour for me.

My point is that what makes he think amrn IP is weak when Pronova actually won their suit against Par/Teva. Has he done any DD and compared Lovaza patents vs Vascepa's ?